212 related articles for article (PubMed ID: 25297632)
1. ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy.
Messai Y; Noman MZ; Hasmim M; Janji B; Tittarelli A; Boutet M; Baud V; Viry E; Billot K; Nanbakhsh A; Ben Safta T; Richon C; Ferlicot S; Donnadieu E; Couve S; Gardie B; Orlanducci F; Albiges L; Thiery J; Olive D; Escudier B; Chouaib S
Cancer Res; 2014 Dec; 74(23):6820-32. PubMed ID: 25297632
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
3. The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing.
Messai Y; Noman MZ; Janji B; Hasmim M; Escudier B; Chouaib S
Autophagy; 2015 Feb; ():0. PubMed ID: 25714778
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.
Baginska J; Viry E; Berchem G; Poli A; Noman MZ; van Moer K; Medves S; Zimmer J; Oudin A; Niclou SP; Bleackley RC; Goping IS; Chouaib S; Janji B
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17450-5. PubMed ID: 24101526
[TBL] [Abstract][Full Text] [Related]
5. Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis.
Liu XD; Yao J; Tripathi DN; Ding Z; Xu Y; Sun M; Zhang J; Bai S; German P; Hoang A; Zhou L; Jonasch D; Zhang X; Conti CJ; Efstathiou E; Tannir NM; Eissa NT; Mills GB; Walker CL; Jonasch E
Oncogene; 2015 May; 34(19):2450-60. PubMed ID: 24998849
[TBL] [Abstract][Full Text] [Related]
6. HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis.
Messai Y; Noman MZ; Hasmim M; Escudier B; Chouaib S
Oncoimmunology; 2015 Feb; 4(2):e985951. PubMed ID: 25949883
[TBL] [Abstract][Full Text] [Related]
7. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
8. Kidney cancer: cracking resistance of RCCs against NK-cell-mediated lysis.
Thoma C
Nat Rev Urol; 2014 Dec; 11(12):662. PubMed ID: 25348168
[No Abstract] [Full Text] [Related]
9. Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
Sourbier C; Srivastava G; Ghosh MC; Ghosh S; Yang Y; Gupta G; Degraff W; Krishna MC; Mitchell JB; Rouault TA; Linehan WM
Oncotarget; 2012 Nov; 3(11):1472-82. PubMed ID: 23178531
[TBL] [Abstract][Full Text] [Related]
10. VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR.
Liu C; Liu L; Wang K; Li XF; Ge LY; Ma RZ; Fan YD; Li LC; Liu ZF; Qiu M; Hao YC; Shi ZF; Xia CY; Strååt K; Huang Y; Ma LL; Xu D
Oncogene; 2020 May; 39(21):4286-4298. PubMed ID: 32291411
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
12. Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.
Walter KM; Schönenberger MJ; Trötzmüller M; Horn M; Elsässer HP; Moser AB; Lucas MS; Schwarz T; Gerber PA; Faust PL; Moch H; Köfeler HC; Krek W; Kovacs WJ
Cell Metab; 2014 Nov; 20(5):882-897. PubMed ID: 25440060
[TBL] [Abstract][Full Text] [Related]
13. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
[TBL] [Abstract][Full Text] [Related]
14. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
15. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy.
Turcotte S; Chan DA; Sutphin PD; Hay MP; Denny WA; Giaccia AJ
Cancer Cell; 2008 Jul; 14(1):90-102. PubMed ID: 18598947
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
[TBL] [Abstract][Full Text] [Related]
17. PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.
Yoshino H; Nohata N; Miyamoto K; Yonemori M; Sakaguchi T; Sugita S; Itesako T; Kofuji S; Nakagawa M; Dahiya R; Enokida H
Cancer Res; 2017 Nov; 77(22):6321-6329. PubMed ID: 28951458
[TBL] [Abstract][Full Text] [Related]
18. CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells.
Trac N; Oh HS; Jones LI; Caliliw R; Ohtake S; Shuch B; Chung EJ
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500549
[TBL] [Abstract][Full Text] [Related]
19. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]